《半日總結》恆指跌377點 科技股弱 藥明生物挫逾22%後停牌
美商務部把33家中國企業加入未覈實清單,藥明生物(02269.HK)股價下瀉逾22%後停牌,港股投資氣氛受打擊,早市向下。恆指低開31點後跌幅擴大,半日跌377點或1.54%,報24,202點;國指跌132點或1.55%,報8,456點;恆生科技指數跌126點或2.28%,報5,403點。大市半日成交總額724.66億元,滬、深港通南下交易半日分別淨流入5.18億及8.83億元人民幣。
藥明生物(02269.HK)附屬及中車集團旗下株洲中車特種裝備科技等被列入美商務部未覈實清單,藥明生物股價急挫後停牌。該股停牌前報62.25元挫22.8%。同系藥明康德(02359.HK)股價半日挫15.1%報96.45元。中車(01766.HK)跌0.5%報2.1元,中車時代電氣(03898.HK)則挫9.7%。
科技股受壓,騰訊(00700.HK)跌1.6%報470.2元,阿裏巴巴(09988.HK)跌3.5%報111元,小米(01810.HK)及京東(09618.HK)各跌2.9%,美團(03690.HK)跌4.1%報216.6元。阿裏健康(00241.HK)及萬國數據(09698.HK)各跌7%。
雲音樂(09899.HK)跌6.3%,汽車之家(02518.HK)、嗶哩嗶哩(09626.HK)及微博(09898.HK)各跌4.3%至6.3%,微盟(02013.HK)及華虹半導體(01347.HK)各跌3.7%及3.8%。
汽車股吉利(00175.HK)及長汽(02333.HK)各跌3.4%及3.6%,比亞迪(01211.HK)跌5%,鋰電池材料商贛鋒鋰業(01772.HK)跌6.3%。華夏幸福債務重組受阻,內房股走軟。世茂(00813.HK)跌3.7%,萬科(02202.HK)、富力(02777.HK)、龍光(03380.HK)及龍湖(00960.HK)各跌2%至2.7%。內地物管股碧服(06098.HK)及華潤萬象生活(01209.HK)各跌3.2%及3.9%。
內需股個別發展,統一企業中國(00220.HK)及康師傅(00322.HK)各升14.2%及5.9%,萬洲(00288.HK)及呷哺呷哺(00520.HK)各升4%及3%,百勝中國(09987.HK)、JS環球生活(01691.HK)、阿裏影業(01060.HK)及海爾智家(06690.HK)各跌3.4%至3.9%,海底撈(06862.HK)、安踏(02020.HK)及李寧(02331.HK)各跌2.5%至2.7%。
金融股匯控(00005.HK)逆升1.6%報58.8元,港交所(00388.HK)跌1%報441元,友邦(01299.HK)升0.2%報85.25元。能源運輸股中遠海能(01138.HK)急升11.9%。
中國龍工(03339.HK)發盈警指去年盈利大減,半日股價挫12.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.